Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: pharmaceutical and medical devices. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. Geographically, just over half of total revenue is generated in the United States.
The current price of Johnson & Johnson in the market is โฉ401,723.85, with a 24-hour trading volume of โฉ0. The asset's market cap is โฉ967.03T, after moving 3.57% in the last day.
Tokenized Johnson & Johnson is trading at โฉ409,438.78, with a tokenized market cap of โฉ65.04B and a 24-hour trading volume of โฉ1.47B. The tokenized asset has moved 0.00% in the past 24 hours.